1) uterine growth
子宫生长
1.
Five effective and commonly used bioassay methods including uterine growth assay, vitellogenin of liver cells assay, MCF-7 cells assay, recombinant yeast assay and yeast two-hybrid assay were reviewed, and their applications in recent research on estrogens in environment were also discussed.
目前对污染物雌激素效应的测评主要依赖于生物学方法,文章主要介绍了子宫生长实验、肝细胞卵黄蛋白原生成实验、人乳腺癌细胞(MCF-7)增值实验、重组基因酵母实验、酵母双杂交实验五种主要的环境雌激素生物检测方法及其在国内外环境激素测评中的应用现状。
2) uterine /growth
子宫/生长
4) Endometrium hyperplasia
子宫内膜增生过长
1.
Objective: To evaluate the effects of levonorgestrol-releasing intrauterine system (LNG-IUS) for treatment of endometrium hyperplasia.
子宫内膜病理示子宫内膜增生过长改变全部消失,内膜呈轻度分泌现象及。
5) poor endometrial development
子宫内膜生长不良
1.
Method A cohort of 50 infertile women with pregnant failures in COH cycle due to poor endometrial development underwent the treatment by oral administration of viagra 50 mg per day from cycle 7~8 d to the day that endometrial thickness reached 8.
方法选择50例促排卵周期中子宫内膜生长不良的不孕患者,在下一个促排卵周期中周期第7~8天开始给予万艾可口服治疗,50mg/d,至子宫内膜厚度达到8。
6) Endometrial hyperplasia
子宫内膜增生过长
1.
Expression of PR, PR-B and the serum level of E_2 , P in endometrial hyperplasia;
子宫内膜增生过长患者雌、孕激素水平、孕激素受体及B亚型的表达
2.
Expression of P27 in endometrial hyperplasia and endometrial adenocarcinoma and its Significance;
P27在子宫内膜增生过长、腺癌中的表达及意义
3.
Objective: The aim of this study was to detect the expression of cyclooxygenase-2(COX-2) in tamoxifen-associated endometrial hyperplasia(tamoxifen-associated "high-risk endometrium") and investigate the effect of celecoxib,a selective COX-2 inhibitor on human endometrioid adenocarcinoma cells(HEC-1-B),thereby investigate the feasibility and mechanism of celecoxib on chemoprevention and treatment.
采用免疫组织化学SP法检测乳腺癌术后口服三苯氧胺(TAM)治疗后(≦5年)的子宫内膜增生过长组织22例,子宫内膜样腺癌9例,正常子宫内膜组织10例中COX-2的分布及表达情况。
补充资料:子宫下
子宫下
病名。见清·沈尧封《女科辑 要·卷下》。即子宫脱垂。详见该条。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条